Home / News / News & Updates / Lung Ambition Awards: A New Canadian Research Awards Program Lung Ambition Awards: A New Canadian Research Awards Program Toronto, Ontario, December 6, 2022 – Today marks the launch of the first annual Lung Ambition Awards, a new Canadian-based lung cancer research awards program designed to help improve the lives of people living with lung cancer. A joint initiative between Lung Cancer Canada, The Lung Ambition Alliance and AstraZeneca Canada, the awards program will have annual grant funding of $100,000 CAD and is open to all Canadian clinicians and researchers from across the multi-disciplinary spectrum of those working in the lung cancer space. It is the largest research awards program of its kind in Lung Cancer Canada’s 20-year history. The Lung Ambition Awards are designed to support research that will help address key gaps in lung cancer care and drive meaningful improvements to the patient care pathway. Awards will be granted in any of the following key areas: Enhancing early detection – including research into methodologies like screening, incidental pulmonary nodules and blood-based testing, particularly for those individuals not eligible under current screening criteria Improving the timeliness and/or coordination of care – including ways in which institutions or healthcare systems can improve care along the patient pathway Addressing disparities to improve equity – including identification of systemic barriers and ways to overcome them “To launch the Lung Ambition Awards on our 20th anniversary is a true testament to how much the lung cancer space has evolved over the past two decades,” said Shem Singh, Executive Director of Lung Cancer Canada, the only national Canadian organization focused solely on lung cancer. “However, there remains a critical need to further improve the experiences and outcomes of lung cancer patients, a group that receives a fraction of research dollars compared to other cancers, despite the devastating effects of the disease.” In Canada, lung cancer is the most diagnosed type of cancer (excluding non-melanoma skin cancers) and the leading cause of death from cancer.[i] Roughly two-thirds of lung cancers are diagnosed in stage III or IV where the disease has spread locally or metastasized.[ii] In Canada, the 5-year survival rate for lung cancer is only 22% – significantly lower than prostate (91%), breast (89%) and colorectal (67%) cancers.[iii] “Along with the Lung Ambition Alliance, we’ve set the bold ambition to one day eliminate lung cancer as a cause of death,” said Mark Sims, Head of Oncology at AstraZeneca Canada. “We know that’s a goal that can only be achieved through impactful collaborations and are proud to support research that will not only improve health outcomes for people with lung cancer, but also contribute to strengthening healthcare capabilities and capacity in the areas of screening, early diagnosis and supportive care." As the program secretariate, Lung Cancer Canada will manage and administer the granting of the awards. AstraZeneca Canada has committed $100,000 CAD per year for the next three years. Submissions for the Lung Ambition Awards will be accepted from December 6, 2022 to February 28, 2023. The review of submissions and selection of winners will be adjudicated solely by Lung Cancer Canada’s Research Committee, and 2 – 3 winners (maximum award of $50,000 CAD each) will be chosen based on scientific merit, feasibility, and relevance to the Canadian lung cancer community. The Lung Ambition Award winners will be announced in April 2023. More information about the Lung Ambition Awards and application guidelines can be found at https://www.lccresearch.ca/. About the Lung Ambition Awards Partners Lung Cancer Canada is a registered national charity that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy. Based in Toronto, Ontario, Lung Cancer Canada has a wide reach that includes both regional and pan-Canadian initiatives. Lung Cancer Canada is a member of the Global Lung Cancer Coalition and is the only national organization in Canada focused exclusively on lung cancer. www.lungcancercanada.ca The Lung Ambition Alliance is a global coalition, with cross-discipline partners in more than 50 countries dedicated to accelerating innovation and driving meaningful improvements for people with lung cancer. With the bold ambition to one day eliminate cancer as a cause of death, the Alliance is focused on three core areas: increasing screening and diagnosis; delivering innovative medicine; and enhancing the quality of care for lung cancer patients. www.lungambitionalliance.com AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development, and commercialization of medicines that transform lives. AstraZeneca’s core areas of scientific focus are Cardiovascular, Renal and Metabolic (CVRM) disease; Oncology; Rare Disease; Respiratory & Immunology; and Vaccine & Immune Therapies. For more information about the Lung Ambition Awards, please contact Winky Yau, Coordinator of Medical Affairs at Lung Cancer Canada at [email protected]. [i] Lung Cancer Canada, 2022 Hard facts infographic, available online at: https://www.lungcancercanada.ca/en-CA/Resources/The-Hard-Facts-Poster.aspx [ii] Statistics Canada, Canadian Cancer Registry (2012–2016) https://www.partnershipagainstcancer.ca/topics/lung-cancer-equity/diagnosis-treatment/ [iii] Lung Cancer Canada, 2022 Hard facts infographic, available online at: https://www.lungcancercanada.ca/en-CA/Resources/The-Hard-Facts-Poster.aspx News News & Updates Current News CANADA'S PREMIER LUNG CANCER FUNDRAISING & AWARENESS EVENT RETURNS JUNE 1st: GIVE A BREATH 5K TORONTO, May 29, 2024 /CNW/ - Lung cancer remains one of the most underfunded and overlooked cancers in Canada, despite being the leading cause of cancer-related deaths. Lung Cancer Canada is calling on all Canadians to join the movement for change by participating in the Give a Breath 5K, the nation's premier fundraising and awareness event dedicated to supporting the lung cancer community. Founded by Tim Monds and his family in 2019, Give a Breath began as a local 5K walk/run in Edmonton and has since grown into a nationwide event. This year's event will take place on June 1st in Edmonton, Halifax, Toronto, Vancouver, and virtually, allowing participants from all over Canada to join in support. "Lung Cancer Canada is thrilled to be partnering with the Monds Family and our event hosts across the country for such an important event," said Shem Singh, Executive Director, Lung Cancer Canada. "With lung cancer impacting more Canadians than any other type of cancer, we need to shine a spotlight on the critical need for increased funding and awareness. Through Give a Breath, and with the support of donors, sponsors, and participants from across Canada, we're doing just that." Funds raised through the Give a Breath 5K support Lung Cancer Canada's Airways of Hope program, ensuring individuals facing lung cancer receive comprehensive care throughout their journey. This program offers healthcare navigation, peer and group support, and one-on-one support from a registered social worker. Additionally, Lung Cancer Canada is excited to announce that, thanks to Give a Breath and the Monds family, it will be expanding its research program with a new research award aimed at supporting the best and brightest minds in lung cancer research in Canada. This new annual award will launch in November 2024 as part of Lung Cancer Awareness Month. This year, there will be two awards of $25,000 each for projects focused on patients with advanced lung cancer, specifically exploring options after first-line therapy. Future announcements will coincide with Give a Breath in early June. Tim Monds, founder of Give a Breath, shared his perspective: "Our family started this event to raise awareness and funds for a cause that has deeply affected us. Seeing Give a Breath grow into a nationwide movement has been incredibly rewarding. We're grateful for the support and look forward to continuing our efforts to make a difference in the lives of those affected by lung cancer." To get involved and help build a movement towards greater awareness and support for lung cancer, visit www.giveabreath.ca. About Lung Cancer Canada: Lung Cancer Canada is a national charity dedicated to increasing awareness, providing patient and caregiver support, advocating for policy change, and funding research to improve outcomes for those affected by lung cancer. Through events like Give a Breath 5K, Lung Cancer Canada aims to rally the community and advocate for the attention and funding that lung cancer desperately needs. SOURCE Lung Cancer Canada For further information: For media inquiries or further information, please contact: Peter Glazier, Senior Advisor, Public Affairs, Communications & Strategy, T. 416.879.1953, E. [email protected] Read More LA CAMPAGNE VEDETTE DE COLLECTE DE FONDS ET DE SENSIBILISATION AU CANCER DU POUMON AU CANADA REVIENT LE 1er JUIN : GIVE A BREATH 5K TORONTO, le 29 mai 2024 /CNW/ - Le cancer du poumon demeure l'un des cancers les moins bien financés et les plus négligés au Canada, bien qu'il soit la principale cause de décès par cancer dans le pays. Cancer pulmonaire Canada invite tous les Canadiens à se joindre au mouvement pour le changement en prenant part au 5K Give a Breath, la campagne vedette de collecte de fonds et de sensibilisation visant à venir en aide à la communauté de personnes affectées par le cancer du poumon. Fondé par Tim Monds et sa famille en 2019, Give a Breath a commencé par une marche/course de 5 km à Edmonton avant de devenir un événement d'envergure nationale. Cette année, l'événement aura lieu le 1er juin à Edmonton, Halifax, Toronto, Vancouver et en virtuel, permettant aux participants de tout le Canada de se joindre au mouvement. « Cancer pulmonaire Canada est ravi de s'associer à la famille Monds et à nos hôtes de partout au pays pour organiser un événement aussi important, a déclaré Shem Singh, directeur général de Cancer pulmonaire Canada. Comme le cancer du poumon touche plus de Canadiens que tout autre type de cancer, nous devons mettre sur le devant de la scène le besoin crucial d'accroître le financement et la sensibilisation. C'est ce que nous faisons grâce à Give a Breath et à l'appui des donateurs, des commanditaires et des participants partout au Canada. » Les fonds amassés par l'entremise de Give a Breath appuient le programme Voies de l'espoir de Cancer pulmonaire Canada, qui vise à aider les personnes atteintes d'un cancer du poumon à recevoir des soins complets tout au long de leur parcours. Ce programme comprend le cheminement dans les soins de santé, le soutien par les pairs et les groupes d'entraide, ainsi que le soutien individuel assuré par un travailleur social agréé. De plus, Cancer pulmonaire Canada est heureux d'annoncer que, grâce à Give a Breath et à la famille Monds, il élargira son programme de recherche grâce à une nouvelle bourse de recherche s'adressant aux esprits les plus brillants de la recherche sur le cancer du poumon au Canada. Ce nouveau prix annuel sera lancé en novembre 2024 dans le cadre du Mois de sensibilisation au cancer du poumon. Cette année, deux prix de 25 000 $ chacun décerné à un projet axé sur les patients atteints d'un cancer du poumon avancé, étudiant plus particulièrement les options après un traitement de première intention. Les prochaines annonces coïncideront avec Give a Breath début juin. Tim Monds, fondateur de Give a Breath, a fait part de son point de vue : « Notre famille a lancé cet événement pour sensibiliser le public et amasser des fonds pour une cause qui nous tient profondément à cœur. Je suis incroyablement gratifié de voir Give a Breath devenir un mouvement national. Nous sommes reconnaissants pour tout le soutien reçu et apportons notre appui aux efforts visant à changer la donne dans la vie des personnes affectées par le cancer du poumon. » Pour participer et aider à créer un mouvement de sensibilisation et de soutien à l'égard du cancer du poumon, rendez-vous sur www.giveabreath.ca. À propos de Cancer pulmonaire Canada: Cancer pulmonaire Canada est un organisme de bienfaisance national qui se voue à la sensibilisation, au soutien des patients et des proches aidants, à la promotion de changements dans les politiques et au financement de la recherche afin d'améliorer les issues cliniques pour les personnes atteintes d'un cancer du poumon. Grâce à des événements, comme le 5K Give a Breath, Cancer pulmonaire Canada vise à rallier la population et à plaider en faveur de l'attention et du financement dont le cancer du poumon a désespérément besoin. SOURCE Lung Cancer Canada Renseignements: Source : Peter Glazier, Conseiller principal, Affaires publiques, communications et stratégie, Tél. : 416 879-1953, Courriel : [email protected] Read More Questions To Ask Clinical Trials Share Your Story Community Activities Make A Donation Peer to Peer Network
Home / News / News & Updates / Lung Ambition Awards: A New Canadian Research Awards Program Lung Ambition Awards: A New Canadian Research Awards Program Toronto, Ontario, December 6, 2022 – Today marks the launch of the first annual Lung Ambition Awards, a new Canadian-based lung cancer research awards program designed to help improve the lives of people living with lung cancer. A joint initiative between Lung Cancer Canada, The Lung Ambition Alliance and AstraZeneca Canada, the awards program will have annual grant funding of $100,000 CAD and is open to all Canadian clinicians and researchers from across the multi-disciplinary spectrum of those working in the lung cancer space. It is the largest research awards program of its kind in Lung Cancer Canada’s 20-year history. The Lung Ambition Awards are designed to support research that will help address key gaps in lung cancer care and drive meaningful improvements to the patient care pathway. Awards will be granted in any of the following key areas: Enhancing early detection – including research into methodologies like screening, incidental pulmonary nodules and blood-based testing, particularly for those individuals not eligible under current screening criteria Improving the timeliness and/or coordination of care – including ways in which institutions or healthcare systems can improve care along the patient pathway Addressing disparities to improve equity – including identification of systemic barriers and ways to overcome them “To launch the Lung Ambition Awards on our 20th anniversary is a true testament to how much the lung cancer space has evolved over the past two decades,” said Shem Singh, Executive Director of Lung Cancer Canada, the only national Canadian organization focused solely on lung cancer. “However, there remains a critical need to further improve the experiences and outcomes of lung cancer patients, a group that receives a fraction of research dollars compared to other cancers, despite the devastating effects of the disease.” In Canada, lung cancer is the most diagnosed type of cancer (excluding non-melanoma skin cancers) and the leading cause of death from cancer.[i] Roughly two-thirds of lung cancers are diagnosed in stage III or IV where the disease has spread locally or metastasized.[ii] In Canada, the 5-year survival rate for lung cancer is only 22% – significantly lower than prostate (91%), breast (89%) and colorectal (67%) cancers.[iii] “Along with the Lung Ambition Alliance, we’ve set the bold ambition to one day eliminate lung cancer as a cause of death,” said Mark Sims, Head of Oncology at AstraZeneca Canada. “We know that’s a goal that can only be achieved through impactful collaborations and are proud to support research that will not only improve health outcomes for people with lung cancer, but also contribute to strengthening healthcare capabilities and capacity in the areas of screening, early diagnosis and supportive care." As the program secretariate, Lung Cancer Canada will manage and administer the granting of the awards. AstraZeneca Canada has committed $100,000 CAD per year for the next three years. Submissions for the Lung Ambition Awards will be accepted from December 6, 2022 to February 28, 2023. The review of submissions and selection of winners will be adjudicated solely by Lung Cancer Canada’s Research Committee, and 2 – 3 winners (maximum award of $50,000 CAD each) will be chosen based on scientific merit, feasibility, and relevance to the Canadian lung cancer community. The Lung Ambition Award winners will be announced in April 2023. More information about the Lung Ambition Awards and application guidelines can be found at https://www.lccresearch.ca/. About the Lung Ambition Awards Partners Lung Cancer Canada is a registered national charity that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy. Based in Toronto, Ontario, Lung Cancer Canada has a wide reach that includes both regional and pan-Canadian initiatives. Lung Cancer Canada is a member of the Global Lung Cancer Coalition and is the only national organization in Canada focused exclusively on lung cancer. www.lungcancercanada.ca The Lung Ambition Alliance is a global coalition, with cross-discipline partners in more than 50 countries dedicated to accelerating innovation and driving meaningful improvements for people with lung cancer. With the bold ambition to one day eliminate cancer as a cause of death, the Alliance is focused on three core areas: increasing screening and diagnosis; delivering innovative medicine; and enhancing the quality of care for lung cancer patients. www.lungambitionalliance.com AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development, and commercialization of medicines that transform lives. AstraZeneca’s core areas of scientific focus are Cardiovascular, Renal and Metabolic (CVRM) disease; Oncology; Rare Disease; Respiratory & Immunology; and Vaccine & Immune Therapies. For more information about the Lung Ambition Awards, please contact Winky Yau, Coordinator of Medical Affairs at Lung Cancer Canada at [email protected]. [i] Lung Cancer Canada, 2022 Hard facts infographic, available online at: https://www.lungcancercanada.ca/en-CA/Resources/The-Hard-Facts-Poster.aspx [ii] Statistics Canada, Canadian Cancer Registry (2012–2016) https://www.partnershipagainstcancer.ca/topics/lung-cancer-equity/diagnosis-treatment/ [iii] Lung Cancer Canada, 2022 Hard facts infographic, available online at: https://www.lungcancercanada.ca/en-CA/Resources/The-Hard-Facts-Poster.aspx News News & Updates Current News CANADA'S PREMIER LUNG CANCER FUNDRAISING & AWARENESS EVENT RETURNS JUNE 1st: GIVE A BREATH 5K TORONTO, May 29, 2024 /CNW/ - Lung cancer remains one of the most underfunded and overlooked cancers in Canada, despite being the leading cause of cancer-related deaths. Lung Cancer Canada is calling on all Canadians to join the movement for change by participating in the Give a Breath 5K, the nation's premier fundraising and awareness event dedicated to supporting the lung cancer community. Founded by Tim Monds and his family in 2019, Give a Breath began as a local 5K walk/run in Edmonton and has since grown into a nationwide event. This year's event will take place on June 1st in Edmonton, Halifax, Toronto, Vancouver, and virtually, allowing participants from all over Canada to join in support. "Lung Cancer Canada is thrilled to be partnering with the Monds Family and our event hosts across the country for such an important event," said Shem Singh, Executive Director, Lung Cancer Canada. "With lung cancer impacting more Canadians than any other type of cancer, we need to shine a spotlight on the critical need for increased funding and awareness. Through Give a Breath, and with the support of donors, sponsors, and participants from across Canada, we're doing just that." Funds raised through the Give a Breath 5K support Lung Cancer Canada's Airways of Hope program, ensuring individuals facing lung cancer receive comprehensive care throughout their journey. This program offers healthcare navigation, peer and group support, and one-on-one support from a registered social worker. Additionally, Lung Cancer Canada is excited to announce that, thanks to Give a Breath and the Monds family, it will be expanding its research program with a new research award aimed at supporting the best and brightest minds in lung cancer research in Canada. This new annual award will launch in November 2024 as part of Lung Cancer Awareness Month. This year, there will be two awards of $25,000 each for projects focused on patients with advanced lung cancer, specifically exploring options after first-line therapy. Future announcements will coincide with Give a Breath in early June. Tim Monds, founder of Give a Breath, shared his perspective: "Our family started this event to raise awareness and funds for a cause that has deeply affected us. Seeing Give a Breath grow into a nationwide movement has been incredibly rewarding. We're grateful for the support and look forward to continuing our efforts to make a difference in the lives of those affected by lung cancer." To get involved and help build a movement towards greater awareness and support for lung cancer, visit www.giveabreath.ca. About Lung Cancer Canada: Lung Cancer Canada is a national charity dedicated to increasing awareness, providing patient and caregiver support, advocating for policy change, and funding research to improve outcomes for those affected by lung cancer. Through events like Give a Breath 5K, Lung Cancer Canada aims to rally the community and advocate for the attention and funding that lung cancer desperately needs. SOURCE Lung Cancer Canada For further information: For media inquiries or further information, please contact: Peter Glazier, Senior Advisor, Public Affairs, Communications & Strategy, T. 416.879.1953, E. [email protected] Read More LA CAMPAGNE VEDETTE DE COLLECTE DE FONDS ET DE SENSIBILISATION AU CANCER DU POUMON AU CANADA REVIENT LE 1er JUIN : GIVE A BREATH 5K TORONTO, le 29 mai 2024 /CNW/ - Le cancer du poumon demeure l'un des cancers les moins bien financés et les plus négligés au Canada, bien qu'il soit la principale cause de décès par cancer dans le pays. Cancer pulmonaire Canada invite tous les Canadiens à se joindre au mouvement pour le changement en prenant part au 5K Give a Breath, la campagne vedette de collecte de fonds et de sensibilisation visant à venir en aide à la communauté de personnes affectées par le cancer du poumon. Fondé par Tim Monds et sa famille en 2019, Give a Breath a commencé par une marche/course de 5 km à Edmonton avant de devenir un événement d'envergure nationale. Cette année, l'événement aura lieu le 1er juin à Edmonton, Halifax, Toronto, Vancouver et en virtuel, permettant aux participants de tout le Canada de se joindre au mouvement. « Cancer pulmonaire Canada est ravi de s'associer à la famille Monds et à nos hôtes de partout au pays pour organiser un événement aussi important, a déclaré Shem Singh, directeur général de Cancer pulmonaire Canada. Comme le cancer du poumon touche plus de Canadiens que tout autre type de cancer, nous devons mettre sur le devant de la scène le besoin crucial d'accroître le financement et la sensibilisation. C'est ce que nous faisons grâce à Give a Breath et à l'appui des donateurs, des commanditaires et des participants partout au Canada. » Les fonds amassés par l'entremise de Give a Breath appuient le programme Voies de l'espoir de Cancer pulmonaire Canada, qui vise à aider les personnes atteintes d'un cancer du poumon à recevoir des soins complets tout au long de leur parcours. Ce programme comprend le cheminement dans les soins de santé, le soutien par les pairs et les groupes d'entraide, ainsi que le soutien individuel assuré par un travailleur social agréé. De plus, Cancer pulmonaire Canada est heureux d'annoncer que, grâce à Give a Breath et à la famille Monds, il élargira son programme de recherche grâce à une nouvelle bourse de recherche s'adressant aux esprits les plus brillants de la recherche sur le cancer du poumon au Canada. Ce nouveau prix annuel sera lancé en novembre 2024 dans le cadre du Mois de sensibilisation au cancer du poumon. Cette année, deux prix de 25 000 $ chacun décerné à un projet axé sur les patients atteints d'un cancer du poumon avancé, étudiant plus particulièrement les options après un traitement de première intention. Les prochaines annonces coïncideront avec Give a Breath début juin. Tim Monds, fondateur de Give a Breath, a fait part de son point de vue : « Notre famille a lancé cet événement pour sensibiliser le public et amasser des fonds pour une cause qui nous tient profondément à cœur. Je suis incroyablement gratifié de voir Give a Breath devenir un mouvement national. Nous sommes reconnaissants pour tout le soutien reçu et apportons notre appui aux efforts visant à changer la donne dans la vie des personnes affectées par le cancer du poumon. » Pour participer et aider à créer un mouvement de sensibilisation et de soutien à l'égard du cancer du poumon, rendez-vous sur www.giveabreath.ca. À propos de Cancer pulmonaire Canada: Cancer pulmonaire Canada est un organisme de bienfaisance national qui se voue à la sensibilisation, au soutien des patients et des proches aidants, à la promotion de changements dans les politiques et au financement de la recherche afin d'améliorer les issues cliniques pour les personnes atteintes d'un cancer du poumon. Grâce à des événements, comme le 5K Give a Breath, Cancer pulmonaire Canada vise à rallier la population et à plaider en faveur de l'attention et du financement dont le cancer du poumon a désespérément besoin. SOURCE Lung Cancer Canada Renseignements: Source : Peter Glazier, Conseiller principal, Affaires publiques, communications et stratégie, Tél. : 416 879-1953, Courriel : [email protected] Read More Questions To Ask Clinical Trials Share Your Story Community Activities Make A Donation Peer to Peer Network